These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28112539)

  • 1. Long-Acting Injectable Antipsychotics in Children and Adolescents.
    Lytle S; McVoy M; Sajatovic M
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):2-9. PubMed ID: 28112539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).
    Novakovic V; Adel T; Peselow E; Lindenmayer JP
    Clin Neuropharmacol; 2013; 36(2):59-62. PubMed ID: 23503549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.
    Pacchiarotti I; Tiihonen J; Kotzalidis GD; Verdolini N; Murru A; Goikolea JM; Valentí M; Aedo A; Vieta E
    Eur Neuropsychopharmacol; 2019 Apr; 29(4):457-470. PubMed ID: 30770235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.
    Gentile S
    Pharmacotherapy; 2013 Oct; 33(10):1087-106. PubMed ID: 23776129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Long-Acting Injectable Antipsychotics in Adolescents.
    Pope S; Zaraa SG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):391-4. PubMed ID: 27028966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.
    Kishimoto T; Nitta M; Borenstein M; Kane JM; Correll CU
    J Clin Psychiatry; 2013 Oct; 74(10):957-65. PubMed ID: 24229745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
    Ostuzzi G; Bertolini F; Del Giovane C; Tedeschi F; Bovo C; Gastaldon C; Nosé M; Ogheri F; Papola D; Purgato M; Turrini G; Correll CU; Barbui C
    Am J Psychiatry; 2021 May; 178(5):424-436. PubMed ID: 33596679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting injectable antipsychotics: evidence of effectiveness and use.
    Manchanda R; Chue P; Malla A; Tibbo P; Roy MA; Williams R; Iyer S; Lutgens D; Banks N
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):5S-13S. PubMed ID: 23945067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.
    Lian L; Kim DD; Procyshyn RM; Cázares D; Honer WG; Barr AM
    PLoS One; 2022; 17(4):e0267808. PubMed ID: 35486616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
    Keramatian K; Chakrabarty T; Yatham LN
    CNS Drugs; 2019 May; 33(5):431-456. PubMed ID: 30963507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.
    Nielsen J; Jensen SO; Friis RB; Valentin JB; Correll CU
    Schizophr Bull; 2015 May; 41(3):627-36. PubMed ID: 25180312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics.
    Misawa F; Kishimoto T; Hagi K; Kane JM; Correll CU
    Schizophr Res; 2016 Oct; 176(2-3):220-230. PubMed ID: 27499361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials.
    Wang D; Schneider-Thoma J; Siafis S; Burschinski A; Dong S; Wu H; Zhu Y; Davis JM; Priller J; Leucht S
    Schizophr Bull; 2024 Jan; 50(1):132-144. PubMed ID: 37350486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
    Correll CU; Citrome L; Haddad PM; Lauriello J; Olfson M; Calloway SM; Kane JM
    J Clin Psychiatry; 2016; 77(suppl 3):1-24. PubMed ID: 27732772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.
    Taylor M; Ng KY
    Aust N Z J Psychiatry; 2013 Jul; 47(7):624-30. PubMed ID: 23209308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging long-acting antipsychotics for the treatment of schizophrenia.
    de Filippis R; De Fazio P; Gaetano R; Steardo L; Cedro C; Bruno A; Zoccali RA; Muscatello MRA
    Expert Opin Drug Saf; 2021 Jul; 20(7):771-790. PubMed ID: 33775184
    [No Abstract]   [Full Text] [Related]  

  • 18. First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.
    Haddad PM; Taylor M; Niaz OS
    Br J Psychiatry Suppl; 2009 Nov; 52():S20-8. PubMed ID: 19880913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance treatment with long-acting injectable risperidone in first-episode schizophrenia: a randomized effectiveness study.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa-McMillan A
    J Clin Psychiatry; 2012 Sep; 73(9):1224-33. PubMed ID: 22938760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis.
    Prajapati AR; Wilson J; Song F; Maidment I
    Bipolar Disord; 2018 Dec; 20(8):687-696. PubMed ID: 30417552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.